Jacobi Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17M | Buy |
14,180
+63
| +0.4% | +$64.4K | 0.83% | 18 |
|
|
2026
Q1 | $13M | Buy |
14,117
+6
| +0% | +$6.08K | 0.73% | 24 |
|
|
2025
Q4 | $15.2M | Sell |
14,111
-455
| -3% | -$435K | 0.88% | 19 |
|
|
2025
Q3 | $11.1M | Buy |
14,566
+766
| +6% | +$570K | 0.68% | 24 |
|
|
2025
Q2 | $10.8M | Buy |
13,800
+30
| +0.2% | +$23.3K | 0.71% | 23 |
|
|
2025
Q1 | $11.4M | Buy |
13,770
+38
| +0.3% | +$31.6K | 0.84% | 15 |
|
|
2024
Q4 | $10.6M | Buy |
13,732
+1,104
| +9% | +$914K | 0.79% | 17 |
|
|
2024
Q3 | $11.2M | Sell |
12,628
-49
| -0.4% | -$44.1K | 0.85% | 14 |
|
|
2024
Q2 | $11.5M | Sell |
12,677
-55
| -0.4% | -$44K | 1% | 13 |
|
|
2024
Q1 | $9.91M | Sell |
12,732
-2,134
| -14% | -$1.52M | 0.92% | 13 |
|
|
2023
Q4 | $8.67M | Sell |
14,866
-1,528
| -9% | -$892K | 0.89% | 18 |
|
|
2023
Q3 | $8.81M | Buy |
16,394
+1,168
| +8% | +$602K | 1% | 11 |
|
|
2023
Q2 | $7.14M | Sell |
15,226
-485
| -3% | -$203K | 0.8% | 18 |
|
|
2023
Q1 | $5.4M | Buy |
15,711
+575
| +4% | +$194K | 0.64% | 25 |
|
|
2022
Q4 | $5.54M | Sell |
15,136
-204
| -1% | -$72.3K | 0.69% | 25 |
|
|
2022
Q3 | $4.96M | Sell |
15,340
-615
| -4% | -$195K | 0.68% | 23 |
|
|
2022
Q2 | $5.17M | Sell |
15,955
-98
| -0.6% | -$29.4K | 0.69% | 25 |
|
|
2022
Q1 | $4.6M | Sell |
16,053
-40
| -0.2% | -$10.3K | 0.55% | 32 |
|
|
2021
Q4 | $4.45M | Buy |
16,093
+195
| +1% | +$49.4K | 0.53% | 30 |
|
|
2021
Q3 | $3.67M | Sell |
15,898
-633
| -4% | -$156K | 0.47% | 33 |
|
|
2021
Q2 | $3.79M | Buy |
16,531
+188
| +1% | +$37.8K | 0.5% | 30 |
|
|
2021
Q1 | $3.05M | Buy |
16,343
+489
| +3% | +$95.7K | 0.45% | 39 |
|
|
2020
Q4 | $3.13M | Buy |
15,854
+165
| +1% | +$24.6K | 0.49% | 32 |
|
|
2020
Q3 | $2.26M | Buy |
15,689
+130
| +0.8% | +$20.1K | 0.4% | 47 |
|
|
2020
Q2 | $2.56M | Sell |
15,559
-261
| -2% | -$40.1K | 0.48% | 35 |
|
|
2020
Q1 | $2.38M | Sell |
15,820
-2,678
| -14% | -$368K | 0.51% | 31 |
|
|
2019
Q4 | $2.52M | Buy |
18,498
+90
| +0.5% | +$10.4K | 0.46% | 42 |
|
|
2019
Q3 | $2.01M | Sell |
18,408
-932
| -5% | -$104K | 0.4% | 49 |
|
|
2019
Q2 | $2.15M | Buy |
19,340
+15,716
| +434% | +$1.85M | 0.44% | 44 |
|
|
2019
Q1 | $470K | Buy |
3,624
+80
| +2% | +$9.73K | 0.12% | 126 |
|
|
2018
Q4 | $410K | Buy |
3,544
+1,678
| +90% | +$187K | 0.11% | 139 |
|
|
2018
Q3 | $200K | Buy |
1,866
+105
| +6% | +$10.5K | 0.05% | 219 |
|
|
2018
Q2 | $150K | Buy |
1,761
+92
| +6% | +$7.56K | 0.04% | 253 |
|
|
2018
Q1 | $126K | Sell |
1,669
-54
| -3% | -$4.35K | 0.04% | 261 |
|
|
2017
Q4 | $148K | Buy |
1,723
+5
| +0.3% | +$425 | 0.05% | 207 |
|
|
2017
Q3 | $150K | Buy |
1,718
+681
| +66% | +$55.9K | 0.05% | 183 |
|
|
2017
Q2 | $85K | Buy |
1,037
+415
| +67% | +$33.9K | 0.03% | 237 |
|
|
2017
Q1 | $53K | Buy |
622
+30
| +5% | +$2.4K | 0.03% | 234 |
|
|
2016
Q4 | $45K | Sell |
592
-30
| -5% | -$2.23K | 0.03% | 228 |
|
|
2016
Q3 | $50K | Buy |
622
+60
| +11% | +$4.8K | 0.02% | 232 |
|
|
2016
Q2 | $45K | Buy |
+562
| New | +$42.3K | 0.02% | 238 |
|
Other funds holding LLY
SC
Jacobi Capital Management's LLY Position: Q2 2026 in Review
Jacobi Capital Management increased its Eli Lilly (LLY) stake by 0.45% in Q2 2026, buying an estimated $64.4K and bringing the position to 14,180 shares worth $17M. The position accounts for 0.83% of the portfolio, ranked #18.
Jacobi Capital Management first reported a position in LLY in Q2 2016 and has held it in 41 quarters since. 2,309 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Jacobi Capital Management held 14,180 shares of Eli Lilly worth $17M as of Q2 2026.
- Jacobi Capital Management bought 63 Eli Lilly shares in Q2 2026, an estimated $64.4K.
- Eli Lilly made up 0.83% of Jacobi Capital Management's portfolio in Q2 2026, its #18 holding.
- Jacobi Capital Management first reported a position in Eli Lilly in Q2 2016 and has held it in 41 quarters since.
- 2,309 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.